HIV related peptides combination or fusion for use in HIV vaccine composition or as diagnostic means

Details for Australian Patent Application No. 2010267996 (hide)

Owner Bionor Immuno AS

Inventors Gronvold, Maja Sommerfelt; Dalgleish, Angus; Lange, Einar Tonnes; Holmberg, Jens Olof; Bengtsson, Per; Sorensen, Birger

Agent FB Rice

Pub. Number AU-A-2010267996

PCT Pub. Number WO2011/000962

Priority 61/223,436 07.07.09 US; 09164565.5 03.07.09 EP

Filing date 3 July 2010

Wipo publication date 6 January 2011

International Classifications

C07K 16/10 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/21 (2006.01) Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 39/42 (2006.01) Medicinal preparations containing antigens or antibodies - viral

C07K 19/00 (2006.01) Hybrid peptides

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2011/000962 Priority application(s): WO2011/000962

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010268006-Catalysed dye systems

2010267983-Talaromyces strains and enzyme compositions